Combo Therapy for Psoriasis With Obesity - Top-Institutions - MDSpire

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

  • By

  • Kathryn Wighton

  • February 18, 2026

  • 3 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Dermatology
    • Endocrinology
    • Obesity Medicine

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Dermatology
    • Obesity Medicine
    • Rheumatology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Dermatology
    • Metabolic Medicine
    • Immunology

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Dermatology
    • Endocrinology
    • Clinical Research

  • #5

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Dermatology
    • Obesity Medicine
    • Translational Research

Original Source(s)

Combo Therapy for Psoriasis With Obesity

  • by Kathryn Wighton

  • February 18, 2026

Related Content

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.

Pediatric Dermatology Clinic now accepting referrals for complex cases

This program provides subspecialty expertise in the diagnosis and management of complex pediatric dermatologic diseases.

  • by

  • May 14, 2026

  • 1 min
Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and